Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HIV
Pharma
ViiV girds data package for Cabenuva in competitive HIV market
Cabenuva hit superior viral suppression versus oral antiretrovirals in adults and adolescents with HIV-1 with viremia in the phase 3b Crown study.
Fraiser Kansteiner
Oct 6, 2026 10:59am
Merck welcomes Debbie Allen into holistic HIV health hive
Sep 28, 2026 2:00am
NICE rebuffs Gilead's twice-yearly PrEP option
Sep 10, 2026 10:12am
Gilead crosses FDA finish line with new HIV combo pill
Aug 27, 2026 5:56pm
ViiV targets ‘future you’ in long-acting HIV campaign
Aug 6, 2026 8:46am
Gilead's Yeztugo faces growth outlook questions
Aug 5, 2026 10:44am
